Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astrana Health, Inc.ASTH · Entity 4538 | SVP - Accounting (PAO) | October 10, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astrana Health, Inc.
Report date October 10, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,774 |
Reported balance
After 2026-10-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-10 · Tax withholding · Disposed 556 · Balance 21,774 F1: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 10, 2026. F2: Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,552 restricted stock units, which will vest on April 10, 2027; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027. F3: Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 10, 2026.
F2: Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,552 restricted stock units, which will vest on April 10, 2027; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027.
F3: Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2026 Filed Oct 13, 2026 20:15 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 556 | $37.55 | $20,877.80 |
DisclosureSEC source: 0001104659-26-115507 · tm2627437-1_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · SVP - Accounting (PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,774 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 10, 2026. F2 · balance_after: Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,552 restricted stock units, which will vest on April 10, 2027; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027. F3 · balance_after: Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 21:53 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 96 | $38.35 | $3,681.60 |
DisclosureSEC source: 0001104659-26-108627 · tm2625575-1_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · SVP - Accounting (PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,330 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 15, 2026. F2 · balance_after: Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 3,104 restricted stock units, which will vest in two equal semi-annual installments beginning on October 10, 2026; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027. F3 · balance_after: Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 30, 2024 Filed Dec 3, 2024 21:15 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 134 | $43.25 | $5,795.50 |
DisclosureSEC source: 0001104659-24-125079 · tm2430064-1_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,520 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock. F2 · balance_after: Includes 11,622 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,887 shares, of which 942 shares will vest on July 11, 2025 and 945 shares will vest on July 11, 2026; (ii) tranches of 380 shares and 380 shares, each of which will vest in two equal annual installments beginning on November 30, 2025; and (iii) tranches of 1,134 shares, 1,134 shares, 1,134 shares, 1,134 shares, and 4,439 shares, each of which will vest in five equal semi-annual installments beginning on May 12, 2025. F3 · balance_after: Includes 76 shares acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:55 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 636 | $42.91 | $27,290.76 |
DisclosureSEC source: 0001104659-24-117790 · tm2428403-1_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,654 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock. F2 · balance_after: Includes 12,002 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,887 shares, of which 942 shares will vest on July 11, 2025 and 945 shares will vest on July 11, 2026; (ii) tranches of 570 shares and 570 shares, each of which will vest in three equal annual installments beginning on November 30, 2024; and (iii) tranches of 1,134 shares, 1,134 shares, 1,134 shares, 1,134 shares, and 4,439 shares, each of which will vest in five equal semi-annual installments beginning on May 12, 2025. F3 · balance_after: Includes 76 shares acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 00:08 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 67 | $51.57 | $3,455.19 |
DisclosureSEC source: 0001104659-24-085987 · tm2420818-1_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,290 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock. F2 · balance_after: Includes 13,793 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,887 shares, of which 942 shares will vest on July 11, 2025 and 945 shares will vest on July 11, 2026; (ii) 570 shares, which will vest in three equal annual installments beginning on November 30, 2024; (iii) 570 shares, which will vest in three equal annual installments beginning on November 30, 2024; (iv) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024; (v) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024; F3 · balance_after: (cont.) (vi) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024; (vii) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024; and (viii) 5,326 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024. F4 · balance_after: Includes 76 shares acquired under the issuer's Employee Stock Purchase Plan. Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 20:15 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 336 | $45.00 | $15,120.00 |
DisclosureSEC source: 0001104659-24-079544 · tm2419388-1_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,357 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock. F2 · balance_after: Includes 13,983 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,887 shares, of which 942 shares will vest on July 11, 2025 and 945 shares will vest on July 11, 2026; (ii) 570 shares, which will vest in three equal annual installments beginning on November 30, 2024; (iii) 760 shares, which will vest upon achievement of certain pre-established performance goals; (iv) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024, subject to the achievement of certain pre-established performance goals; (v) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024, subject to the achievement of certain pre-established performance goals; F3 · balance_after: (cont.) (vi) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024, subject to the achievement of certain pre-established performance goals; (vii) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024, subject to the achievement of certain pre-established performance goals; and (viii) 5,326 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024. F4 · balance_after: Includes 76 shares acquired under the issuer's Employee Stock Purchase Plan. Read SEC document |
| May 12, 2024 Filed May 14, 2024 20:36 UTC | Astrana Health, Inc. ASTH · Entity 4538 | Tax withholdingCommon Stock | 636 | $38.89 | $24,734.04 |
DisclosureSEC source: 0001104659-24-061197 · tm2414489-1_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,617 F1 · shares: Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock. F2 · balance_after: Includes 14,927 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares will vest on each of July 11, 2024 and July 11, 2025 and 945 shares will vest on July 11, 2026; (ii) 570 shares, which will vest in three equal annual installments beginning on November 30, 2024; (iii) 760 shares, which will vest upon achievement of certain pre-established performance goals; (iv) 1,361 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024, subject to the achievement of certain pre-established performance goals; (v) 1,361 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024, subject to the achievement of certain pre-established performance goals; F3 · balance_after: (cont.) (vi) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024, subject to the achievement of certain pre-established performance goals; (vii) 1,360 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024, subject to the achievement of certain pre-established performance goals; and (viii) 5,326 shares, which will vest in six equal semi-annual installments beginning on November 12, 2024. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 02:10 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 7,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 5 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,253 F5 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 887 shares of restricted stock will vest on December 31, 2023, and the remaining 6,213 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024. F6 · balance_after: Includes 18,511 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares will vest on each of July 11, 2024 and July 11, 2025 and 945 shares will vest on July 11, 2026; (ii) 570 shares, which will vest in three equal annual installments beginning on November 30, 2024; (iii) 760 shares, which will vest upon achievement of certain pre-established performance goals; (iv) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; (v) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; F7 · balance_after: (cont.) (vi) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; (vii) 1,813 shares, of which 226 shares will vest on December 31, 2023 and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024, subject to the achievement of certain pre-established performance goals; and (viii) 7,100 shares, of which 887 shares will vest on December 31, 2023, and the remaining shares will vest in seven equal semi-annual installments beginning on May 12, 2024. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 02:10 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 1,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 4 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,153 F4 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 02:10 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 1,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 3 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,340 F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 02:10 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 1,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 2 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,527 F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 02:10 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 1,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-127452 · tm2333076-9_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,714 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, 226 shares of restricted stock will vest on December 31, 2023, and the remaining 1,587 shares of restricted stock shall vest in seven substantially equal semi-annual installments beginning on May 12, 2024. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 02:10 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Tax withholdingCommon Stock | 65 | $33.23 | $2,159.95 |
DisclosureSEC source: 0001104659-23-123379 · tm2332139-1_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,901 F1 · shares: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award that vested on November 30, 2023. F2 · balance_after: Includes 4,159 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares vest on each of July 11, 2024 and July 11, 2025 and 945 shares vest on July 11, 2026; (ii) 570 shares, which vest in three equal annual installments beginning on November 30, 2024; and (iii) 760 shares, which will vest upon achievement of certain pre-established performance goals. Read SEC document |
| July 11, 2023 Filed Nov 16, 2023 21:30 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Tax withholdingCommon Stock | 325 | $32.07 | $10,422.75 |
DisclosureSEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 8 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,966 F6 · shares: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award that vested on July 11, 2023. F7 · balance_after: Includes 4,349 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares vest on each of July 11, 2024 and July 11, 2025 and 945 shares vest on July 11, 2026; (ii) 760 shares, which vest in four equal annual installments beginning on November 30, 2023; and (iii) 760 shares, which vest upon achievement of certain pre-established performance goals. Read SEC document |
| July 01, 2023 Filed Nov 16, 2023 21:30 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Disposition to issuerCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 7 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,291 F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited. Read SEC document |
| July 01, 2023 Filed Nov 16, 2023 21:30 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Disposition to issuerCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 6 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,811 F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited. Read SEC document |
| May 16, 2023 Filed Nov 16, 2023 21:30 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 760 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 5 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,331 F5 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal. Read SEC document |
| May 16, 2023 Filed Nov 16, 2023 21:30 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 760 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 4 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,571 F4 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before July 1, 2023, which performance goal was met. Read SEC document |
| May 16, 2023 Filed Nov 16, 2023 21:30 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 3 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,811 F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited. Read SEC document |
| May 16, 2023 Filed Nov 16, 2023 21:30 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 2 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,291 F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited. Read SEC document |
| May 16, 2023 Filed Nov 16, 2023 21:30 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Disposition to issuerCommon Stock | 4,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-119141 · tm2330683-2_4seq1.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,771 F1 · shares: Represents cancellation of all performance-based restricted stock awards granted on December 12, 2022. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 23:11 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 694 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-031872 · wf-form4_167097305185321.xml · nonDerivative · entry 4 Vong John · CIK 0001572846 · SVP-Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,935 F4 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 519 shares shall vest in three equal annual installments beginning on November 30, 2023. The remaining 175 shall vest on November 30, 2026. Such vesting is subject to achievement of a pre-established performance goal on or before November 30, 2026. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 23:11 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 694 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-031872 · wf-form4_167097305185321.xml · nonDerivative · entry 3 Vong John · CIK 0001572846 · SVP-Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,241 F3 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 519 shares shall vest in three equal annual installments beginning on November 30, 2023. The remaining 175 shall vest on November 30, 2026. Such vesting is subject to achievement of a pre-established performance goal on or before April 1, 2023. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 23:11 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 1,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-031872 · wf-form4_167097305185321.xml · nonDerivative · entry 2 Vong John · CIK 0001572846 · SVP-Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,547 F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before July 1, 2023. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 23:11 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 1,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-031872 · wf-form4_167097305185321.xml · nonDerivative · entry 1 Vong John · CIK 0001572846 · SVP-Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,159 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before April 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.